Annual Total Debt
$51.51 M
+$4.29 M+9.07%
December 31, 2022
Summary
- As of February 11, 2025, MRTX annual total debt is $51.51 million, with the most recent change of +$4.29 million (+9.07%) on December 31, 2022.
- During the last 3 years, MRTX annual total debt has risen by +$51.51 million (+100.00%).
Performance
MRTX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Debt
$50.22 M
-$460.00 K-0.91%
September 30, 2023
Summary
- As of February 11, 2025, MRTX quarterly total debt is $50.22 million, with the most recent change of -$460.00 thousand (-0.91%) on September 30, 2023.
- Over the past year, MRTX quarterly total debt has dropped by -$1.04 million (-2.02%).
Performance
MRTX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
MRTX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.1% | -2.0% |
| 3 y3 years | +100.0% | +100.0% |
| 5 y5 years | +100.0% | +100.0% |
MRTX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -8.3% | -2.5% | -8.7% |
| 5 y | 5-year | at high | -100.0% | -2.5% | -100.0% |
| alltime | all time | at high | -100.0% | -2.5% | -100.0% |
Mirati Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $50.22 M(-0.9%) |
| Jun 2023 | - | $50.68 M(-0.9%) |
| Mar 2023 | - | $51.13 M(-0.7%) |
| Dec 2022 | $51.51 M(+9.1%) | $51.51 M(+0.5%) |
| Sep 2022 | - | $51.26 M(+2.3%) |
| Jun 2022 | - | $50.13 M(+9.4%) |
| Mar 2022 | - | $45.83 M(-2.9%) |
| Dec 2021 | $47.22 M(+12.7%) | $47.22 M(+3.7%) |
| Sep 2021 | - | $45.52 M(+2.3%) |
| Jun 2021 | - | $44.48 M(+3.0%) |
| Mar 2021 | - | $43.17 M(+3.0%) |
| Dec 2020 | $41.91 M(>+9900.0%) | $41.91 M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2019 | - | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00 | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $787.10 K(+100.8%) |
| Dec 2010 | $391.90 K(-28.8%) | $391.90 K(-5.5%) |
| Sep 2010 | - | $414.80 K(+125.4%) |
| Jun 2010 | - | $184.00 K(-64.4%) |
| Mar 2010 | - | $517.00 K(-6.0%) |
| Dec 2009 | $550.10 K(+13.3%) | $550.10 K(-82.9%) |
| Sep 2009 | - | $3.22 M(+3.1%) |
| Jun 2009 | - | $3.13 M(+3.5%) |
| Mar 2009 | - | $3.02 M(+521.9%) |
| Dec 2008 | $485.70 K(-32.2%) | $485.70 K(>+9900.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(-100.0%) |
| Dec 2007 | $716.90 K(>+9900.0%) | $716.90 K(>+9900.0%) |
| Sep 2007 | - | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(-100.0%) |
| Jun 2006 | - | $900.00(-65.4%) |
| Mar 2006 | - | $2600.00(-53.6%) |
| Dec 2005 | $5600.00(-97.6%) | $5600.00(-43.4%) |
| Sep 2005 | - | $9900.00(-27.2%) |
| Jun 2005 | - | $13.60 K(-24.0%) |
| Mar 2005 | - | $17.90 K |
| Dec 2004 | $237.20 K(-65.2%) | - |
| Dec 2003 | $682.20 K | - |
FAQ
- What is Mirati Therapeutics annual total debt?
- What is the all time high annual total debt for Mirati Therapeutics?
- What is Mirati Therapeutics annual total debt year-on-year change?
- What is Mirati Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly total debt year-on-year change?
What is Mirati Therapeutics annual total debt?
The current annual total debt of MRTX is $51.51 M
What is the all time high annual total debt for Mirati Therapeutics?
Mirati Therapeutics all-time high annual total debt is $51.51 M
What is Mirati Therapeutics annual total debt year-on-year change?
Over the past year, MRTX annual total debt has changed by +$4.29 M (+9.07%)
What is Mirati Therapeutics quarterly total debt?
The current quarterly total debt of MRTX is $50.22 M
What is the all time high quarterly total debt for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly total debt is $51.51 M
What is Mirati Therapeutics quarterly total debt year-on-year change?
Over the past year, MRTX quarterly total debt has changed by -$1.04 M (-2.02%)